Logic-Gated T-Cell Engagers for Expanding Therapeutic Index for Deeper Efficacy & Favourable Safety

• Harness computational protein design and modelling for next-gen TCE platform
• Lead program focused on “AND”-gated design that enhances tumour selectivity while minimising on-target off-tumour toxicities
• Platform modularity provides an opportunity to generate multiple therapeutic TCEs for various solid tumours

Speakers:

Anish Suri

Executive Vice President & Chief Scientific Officer

Synolo Therapeutics